Literature DB >> 26547434

First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Kjetil N Jørgensen1,2, Ragnar Nesvåg3,4, Sindre Gunleiksrud3, Andrea Raballo3,5, Erik G Jönsson5,6, Ingrid Agartz3,5,6.   

Abstract

Antipsychotic medication may influence brain structure, but to what extent effects of first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) differ is still not clear. Here we aimed to disentangle the effects of FGA and SGA on variation in volumes of subcortical structures in patients with long-term treated schizophrenia. Magnetic resonance images were obtained from 95 patients with schizophrenia and 106 healthy control subjects. Among the patients, 40 received only FGA and 42 received only SGA. FreeSurfer 5.3.0 was used to obtain volumes of 27 subcortical structures as well as total brain volume and estimated intracranial volume. Findings of reduced total brain volume, enlarged ventricular volume and reduced hippocampal volume bilaterally among patients were replicated, largely independent of medication class. In the basal ganglia, FGA users had larger putamen bilaterally and right caudate volume compared to healthy controls, and the right putamen was significantly larger than among SGA users. FGA and SGA users had similar and larger globus pallidus volumes compared to healthy controls. Post hoc analyses revealed that the difference between FGA and SGA could be attributed to smaller volumes in the clozapine users specifically. We therefore conclude that basal ganglia volume enlargements are not specific to FGA.

Entities:  

Keywords:  Antipsychotic medication; Basal ganglia; Clozapine; Magnetic resonance imaging; Schizophrenia; Subcortical brain structures

Mesh:

Substances:

Year:  2015        PMID: 26547434     DOI: 10.1007/s00406-015-0650-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  62 in total

1.  The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.

Authors:  Karl-Anton Dorph-Petersen; Joseph N Pierri; James M Perel; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

Review 2.  Update on typical and atypical antipsychotic drugs.

Authors:  Herbert Y Meltzer
Journal:  Annu Rev Med       Date:  2012-09-27       Impact factor: 13.739

3.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.

Authors:  M H Chakos; J A Lieberman; J Alvir; R Bilder; M Ashtari
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

4.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Authors:  M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

5.  Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures.

Authors:  Maria Vares; Andreas Ekholm; Göran C Sedvall; Håkan Hall; Erik G Jönsson
Journal:  Psychopathology       Date:  2006-09-08       Impact factor: 1.944

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.

Authors:  Bjørn H Ebdrup; Arnold Skimminge; Hans Rasmussen; Bodil Aggernaes; Bob Oranje; Henrik Lublin; William Baaré; Birte Glenthøj
Journal:  Int J Neuropsychopharmacol       Date:  2010-08-12       Impact factor: 5.176

8.  Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Authors:  Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti
Journal:  Psychiatry Res       Date:  2013-10-22       Impact factor: 3.222

9.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

Review 10.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

View more
  12 in total

1.  Subcortical structures and cognitive dysfunction in first episode schizophrenia.

Authors:  Fengmei Fan; Hong Xiang; Shuping Tan; Fude Yang; Hongzhen Fan; Hua Guo; Peter Kochunov; Zhiren Wang; L Elliot Hong; Yunlong Tan
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-12       Impact factor: 2.376

2.  A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits.

Authors:  Qiannan Zhao; Hengyi Cao; Wenjing Zhang; Siyi Li; Yuan Xiao; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Scot Kristian Hill; Sarah K Keedy; Elena I Ivleva; Rebekka Lencer; John A Sweeney; Qiyong Gong; Su Lui
Journal:  Neuropsychopharmacology       Date:  2022-03-08       Impact factor: 8.294

3.  Cortical Morphometry in the Psychosis Risk Period: A Comprehensive Perspective of Surface Features.

Authors:  Katherine S F Damme; Tina Gupta; Robin Nusslock; Jessica A Bernard; Joseph M Orr; Vijay A Mittal
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-31

4.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.

Authors:  Fernando Caravaggio; Gagan Fervaha; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Shinichiro Nakajima; Wanna Mar; Philip Gerretsen; Julia Kim; M Mallar Chakravarty; Benoit Mulsant; Bruce Pollock; David Mamo; Gary Remington; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2017-11-07       Impact factor: 3.485

5.  The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects.

Authors:  Naoki Hashimoto; Yoichi M Ito; Naohiro Okada; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Noriko Kudo; Ariyoshi Takemura; Shuraku Son; Hisashi Narita; Maeri Yamamoto; Khin Khin Tha; Asuka Katsuki; Kazutaka Ohi; Fumio Yamashita; Shinsuke Koike; Tsutomu Takahashi; Kiyotaka Nemoto; Masaki Fukunaga; Toshiaki Onitsuka; Yoshiyuki Watanabe; Hidenori Yamasue; Michio Suzuki; Kiyoto Kasai; Ichiro Kusumi; Ryota Hashimoto
Journal:  Neuroimage Clin       Date:  2017-11-08       Impact factor: 4.881

6.  Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients.

Authors:  Helle G Andersen; Jayachandra M Raghava; Claus Svarer; Sanne Wulff; Louise B Johansen; Patrick K Antonsen; Mette Ø Nielsen; Egill Rostrup; Anthony C Vernon; Lars T Jensen; Lars H Pinborg; Birte Y Glenthøj; Bjørn H Ebdrup
Journal:  Front Neurosci       Date:  2020-05-20       Impact factor: 4.677

7.  Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV.

Authors:  Benjamin S C Wade; Victor G Valcour; Thanyawee Puthanakit; Arvin Saremi; Boris A Gutman; Talia M Nir; Christa Watson; Linda Aurpibul; Pope Kosalaraksa; Pradthana Ounchanum; Stephen Kerr; Netsiri Dumrongpisutikul; Pannee Visrutaratna; Jiraporn Srinakarin; Monthana Pothisri; Katherine L Narr; Paul M Thompson; Jintanat Ananworanich; Robert H Paul; Neda Jahanshad
Journal:  Neuroimage Clin       Date:  2019-04-02       Impact factor: 4.881

Review 8.  Short-term mechanisms influencing volumetric brain dynamics.

Authors:  Nikki Dieleman; Huiberdina L Koek; Jeroen Hendrikse
Journal:  Neuroimage Clin       Date:  2017-09-06       Impact factor: 4.881

9.  Distinct structural brain circuits indicate mood and apathy profiles in bipolar disorder.

Authors:  Wenhao Jiang; Ole A Andreassen; Ingrid Agartz; Trine V Lagerberg; Lars T Westlye; Vince D Calhoun; Jessica A Turner
Journal:  Neuroimage Clin       Date:  2019-08-19       Impact factor: 4.881

10.  Microstructural White Matter and Links With Subcortical Structures in Chronic Schizophrenia: A Free-Water Imaging Approach.

Authors:  Tiril P Gurholt; Unn K Haukvik; Vera Lonning; Erik G Jönsson; Ofer Pasternak; Ingrid Agartz
Journal:  Front Psychiatry       Date:  2020-02-27       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.